China Universal Asset Management Co., Ltd. Rapt Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $700 Million
- Q2 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 4,101 shares of RAPT stock, worth $9,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,101
Previous 6,602
37.88%
Holding current value
$9,227
Previous $59,000
79.66%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding RAPT
# of Institutions
125Shares Held
29.1MCall Options Held
905KPut Options Held
592K-
Vanguard Group Inc Valley Forge, PA3.11MShares$6.99 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$6.03 Million11.48% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$5.49 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$3.88 Million0.61% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$3.6 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $66.7M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...